YAP1 and Alzheimer disease: In addition to the role of Hippo activation in neuronal dysfunction and death described above, alterations in Hippo signaling leading to reduced YAP levels may also occur in glial cells, contributing to AD pathogenesis through non-neuronal mechanisms.